发明名称 SELECTIVE ESTROGEN RECEPTOR MODULATOR IN COMBINATION WITH DENYDROEPIANDROSTERONE (DHEA) OR ANALOGUES
摘要 Novel methods for the medical treatment and/or inhibition of the development of osteoporosis, breast cancer, hypercholesterolemia, hyperlipidemia or atherosclerosis in susceptible warm-blooded animals including humans involving administration of selective estrogen receptor modulator particularly compounds having general structure (I) and an amount of a sex steroid precursor selected from the group consisting of dehydroepiandrosterone, dehydroepiandrosterone sulfate, androst-5-ene-3beta,17beta-diol and compounds converted in vivo to one of the foregoing precursor. Further administration of bisphosphonates in combination with selective estrogen receptor modulators and/or sex steroid precursor is disclosed for the medical treatment and/or inhibition of the development of osteoporosis. Pharmaceutical compositions for delivery of active ingredient(s) and kit(s) useful to the invention are also disclosed.
申请公布号 KR20090018227(A) 申请公布日期 2009.02.19
申请号 KR20097001804 申请日期 2009.01.28
申请人 ENDORECHERCHE INC. 发明人 LABRIE FERNAND
分类号 A61K31/5685;C07D333/56;A61K31/133;A61K31/381;A61K31/40;A61K31/4025;A61K31/403;A61K31/404;A61K31/4436;A61K31/4453;A61K31/453;A61K31/475;A61K31/56;A61K31/565;A61K31/568;A61K31/57;A61K31/66;A61K45/00;A61K45/06;A61P3/06;A61P9/10;A61P15/00;A61P15/02;A61P19/10;A61P21/00;A61P35/00;C07D209/10;C07D311/60 主分类号 A61K31/5685
代理机构 代理人
主权项
地址